| 臺大學術典藏 |
2021-03-17T02:32:21Z |
Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV
|
Chen, Guan-Jhou;Lee, Yu-Lin;Lee, Chen-Hsiang;Sun, Hsin-Yun;Cheng, Chien-Yu;Tsai, Hung-Chin;Huang, Sung-Hsi;Lee, Yi-Chieh;Hsieh, Min-Han;Sui-Yuan Chang;Chuang, Yu-Chung;Su, Li-Shin;Chang, Sui-Fang;Tang, Hung-Jen;Hung, Chien-Ching; Chen, Guan-Jhou; Lee, Yu-Lin; Lee, Chen-Hsiang; Sun, Hsin-Yun; Cheng, Chien-Yu; Tsai, Hung-Chin; Huang, Sung-Hsi; Lee, Yi-Chieh; Hsieh, Min-Han; SUI-YUAN CHANG; Chuang, Yu-Chung; Su, Li-Shin; Chang, Sui-Fang; Tang, Hung-Jen; Hung, Chien-Ching |
